Revascor adult stem cells: Phase II ongoing

Angioblast completed enrollment of 20 patients in the second cohort of a single-blind, dose-escalation, U.S. Phase II trial (HF-AB002) comparing 3 dose levels of Revascor vs. standard of care in up to...